Organigram Holdings Inc. (TSE:OGI – Free Report) – Equities researchers at Atb Cap Markets issued their Q1 2025 earnings estimates for shares of Organigram in a research note issued to investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.
A number of other research firms also recently issued reports on OGI. Canaccord Genuity Group reduced their price target on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating for the company in a research report on Monday, December 9th. ATB Capital dropped their price objective on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.
Organigram Stock Up 6.2 %
OGI stock opened at C$2.22 on Monday. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The company’s 50-day moving average price is C$2.26 and its 200 day moving average price is C$2.30. Organigram has a 52 week low of C$1.61 and a 52 week high of C$3.95. The company has a market cap of C$241.03 million, a P/E ratio of -0.88, a P/E/G ratio of 0.42 and a beta of 1.13.
Insider Buying and Selling at Organigram
In other news, Senior Officer Paolo De Luca sold 12,014 shares of the business’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is currently owned by insiders.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
- Five stocks we like better than Organigram
- How to Find Undervalued Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- 3 Healthcare Dividend Stocks to Buy
- CarMax Gets in Gear: Is Now the Time to Buy?
- What Does a Stock Split Mean?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.